secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001683168-24-000489
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharmaceuticals receives Nasdaq delisting notice for bid price below $1.00
-------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Jan 24, 2024; stock failed to maintain $1.00 minimum bid for 30 consecutive business days.
- Initial compliance period ends July 22, 2024; can regain by closing at $1.00 or more for 10 consecutive business days.
- No immediate effect on listing or trading; company evaluating options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/0001683168-24-000489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer